AbbVie
ABBV
#28
Rank
โ‚ฌ306.74 B
Marketcap
173,58ย โ‚ฌ
Share price
0.40%
Change (1 day)
31.10%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2024 (TTM): โ‚ฌ6.58 Billion

According to AbbVie's latest financial reports the company's current earnings are โ‚ฌ55.53 Billion. In 2023 the company made an earning of โ‚ฌ5.94 Billion a decrease over its 2022 earnings that were of โ‚ฌ12.81 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) โ‚ฌ6.58 B10.83%
2023 โ‚ฌ5.94 B-53.62%
2022 โ‚ฌ12.81 B3.76%
2021 โ‚ฌ12.35 B282.25%
2020 โ‚ฌ3.23 B-59.67%
2019 โ‚ฌ8.01 B62.13%
2018 โ‚ฌ4.94 B-32.74%
2017 โ‚ฌ7.34 B-1.99%
2016 โ‚ฌ7.49 B18.65%
2015 โ‚ฌ6.32 B180.5%
2014 โ‚ฌ2.25 B-55.57%
2013 โ‚ฌ5.07 B-6.86%
2012 โ‚ฌ5.44 B56.05%
2011 โ‚ฌ3.48 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚ฌ6.60 B-3.53%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ6.55 Billion-195.60%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ9.65 B 41.04%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ4.45 B-34.99%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.16 B-97.55%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.81 B-73.52%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ3.96 B-42.05%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ9.17 B 33.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ0.62 B-90.88%๐Ÿ‡บ๐Ÿ‡ธ USA